2 citations
,
  September 2012   in “Pharmaceutical patent analyst”    European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.  
     
           1 citations
,
  April 2009   in “Journal of Intellectual Property Law & Practice”    UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.  
     
           July 2008   in “Journal of Intellectual Property Law & Practice”    The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.  
     
           July 2008   in “Journal of Intellectual Property Law & Practice”    The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.  
     
           July 2008   in “Journal of Intellectual Property Law & Practice”    Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.